Stay updated with breaking news from Roberta Michael. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cambridge Investment Research Advisors Inc. trimmed its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 8.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 487,742 shares of the company’s stock after selling 44,986 shares during the period. […]
Comprehensive Analysis of AbbVie's Latest Financial Performance
Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These...
Sales of the pharma giant's newer drugs are offsetting its Humira losses.
(CTN News) - The AbbVie company raised its full-year profit guidance today, despite sales of its flagship product continuing to decline.................